In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate Cancer Models
- 19 January 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (7) , 708-717
- https://doi.org/10.1002/pros.20392
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Negative Prostatic Biopsies in Patients with a High Risk of Prostate Cancer: Is the Combination of Endorectal MRI and Magnetic Resonance Spectroscopy Imaging (MRSI) a Useful Tool? A Preliminary StudyEuropean Urology, 2005
- New poly(lactic-co-glycolic acid) derivatives: Modular polymers with tailored propertiesDrug Discovery Today: Technologies, 2005
- Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotypeJournal of Cellular Biochemistry, 2004
- Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate CancerJournal of Urology, 2003
- Transition Zone Prostate Cancer: Metabolic Characteristics at1H MR Spectroscopic Imaging—Initial ResultsRadiology, 2003
- Myc-driven murine prostate cancer shares molecular features with human prostate tumorsCancer Cell, 2003
- Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT modelProceedings of the National Academy of Sciences, 2003
- Haploinsufficiency at the Nkx3.1 locusCancer Cell, 2003
- In vivo multiple-mouse imaging at 1.5 TMagnetic Resonance in Medicine, 2003
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995